Sanarus Technologies logo — company profile

Sanarus Technologies

Founded 2009 United States Pleasanton, United States 9 employees Series E Total: $70.92M Health Care, Women's Health

General Information

Company Name Sanarus Technologies
Founded Year 2009
Location United States Pleasanton, United States +1
Employees 9
Industries Health Care, Women's Health
Funding Stage Series E
Social

Get notified when Sanarus Technologies moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Sanarus Technologies

Sanarus Technologies is a Health Care startup based in the United States that has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. With FDA clearance for non-cancerous breast tumors (fibroadenomas), Sanarus is currently sponsoring the FROST Clinical Study for early stage breast cancer that does not involve surgical resection. The company received a $15.00M Series E investment from Easton Capital, US Venture Partners, Alta Partners, Forward Ventures, Channel Medical Partners, Pequot Capital, and Federated Investors on 20 February 2007. Sanarus is committed to raising awareness of cryoablation as a treatment option throughout the community and major breast cancer organizations, in hopes of making it the standard of care for breast tumors. More information can be found on their website, www.sanarus.com, and their Twitter account, www.twitter.com/SanarusTech.

Taxonomy: Minimally Invasive Surgery, Breast Cancer Treatment, Cryoablation, Image-Guided Therapy, FDA Clearance, Clinical Study, Non-Surgical Treatment, Patient Awareness, Physician Adoption

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series E •••••• 7
Investor Investor Investor Investor Investor
•••• ••••
20 Feb 2007
Series D •••••• 3
Investor Investor
•••• ••••
13 Apr 2005
Series C •••••• - 13 Nov 2003
Series B •••••• - 24 Jul 2001
Series A •••••• - 22 Mar 2000

Sanarus Technologies Alternatives & Competitors

Sanarus Technologies vs

The Choice of Cryoablation

Post Ipo Equity
70 employees
Biotechnology, Health Care
Sanarus Technologies vs
Novian Health
Novian Health United States

A LEADING COMPANY IN IMAGE-GUIDED LASER TUMOR THERAPY

Convertible Note
9 employees
Health Care, Health and Wellness
Sanarus Technologies vs
Marvel Medtech
Marvel Medtech United States

Putting the Preventative in Breast Cancer Treatment

2 employees
Biotechnology, Health Care

FAQ About Sanarus Technologies

Sanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. This breast conserving treatment is available at part...
Sanarus Technologies was founded in 2009.
Sanarus Technologies is headquartered in Pleasanton, United States.
Sanarus Technologies operates in the following industries: Health Care, Women's Health.
Sanarus Technologies has approximately 9 employees.
Sanarus Technologies has completed 5 funding rounds, raising a total of $70.92M. The latest funding stage is Series E.
Top alternatives and competitors to Sanarus Technologies include IceCure Medical, Novian Health, Marvel Medtech, MITOS Medical Technologies A.S., Hercules Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sanarus Technologies and IceCure Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sanarus Technologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy